Literature DB >> 7053406

Biochemical evidence for the coexistence of monomorphic and polymorphic N-acetyltransferase activities on a common protein in rabbit liver.

D W Hein, M Hirata, I B Glowinski, W W Weber.   

Abstract

New Zealand White rabbits were classified as rapid or slow acetylators by measuring the N-acetylation half-life of i.v. administered sulfadiazine, by pedigree analysis and by determination of liver N-acetyltransferase (NAT) activity in vitro. Slow acetylator rabbits were found to have significantly lower levels of p-aminobenzoic acid NAT activity in vitro than did rapid acetylator rabbits, demonstrating genetic covariation of p-aminobenzoic acid (monomorphic) and isoniazid (polymorphic) NAT activity. Monomorphic and polymorphic NAT activities could not be separated by two extensive purification procedures involving sequential centrifugation, fractional precipitation with ammonium sulfate, ion-exchange chromatography on DEAE-cellulose, gel filtration on Sephadex or Sephacryl and isoelectric focusing or electrophoresis on polyacrylamide gels. In addition, indistinguishable heat inactivation patterns were demonstrated for the two NAT activities utilizing highly purified NAT preparations at two different temperatures. Each of these findings support the coexistence of monomorphic and polymorphic NAT activities on a common protein.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053406

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  H W Eckerson; C M Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

2.  Distribution of acetylator phenotype in relation to age and sex in Swedish patients. A retrospective study.

Authors:  O Paulsen; L G Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice.

Authors:  Jennifer A Loehle; Valerie Cornish; Larissa Wakefield; Mark A Doll; Jason R Neale; Yu Zang; Edith Sim; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2006-07-20       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.